Literature DB >> 10065032

Animal experimental implantation of an atrial septal defect occluder system.

A Bloch Thomsen1, M Schneider, U Baandrup, E V Stenbøg, J M Hasenkam, J P Bagger, G Hausdorf.   

Abstract

OBJECTIVE: To establish the implantation technique for the atrial septal defect occluder system (ASDOS) device in an experimental animal model and to determine long term mechanical stability of the device and its in vivo properties in terms of biocompatibility and tissue reaction.
MATERIALS AND METHODS: An atrial septal defect was created and the device implanted in 17 pigs (mean weight 30 kg). The implantation technique was refined and modified because of initial technical and anatomical complications during nine acute pilot studies. The technique proved to be feasible in eight subsequent survival studies. Four pigs were electively killed three months after implantation (group 1). The remaining four pigs were killed six months after implantation (group 2).
RESULTS: Necropsy showed all devices were embedded in soft tissue three months after implantation. Microscopic examination of atrial septal tissue showed an acute granulomatous inflammatory reaction in group 1 and fibrosis in group 2. The intensity of the inflammatory reaction around the device was clearly milder in group 2, indicating a decline in the inflammatory response with time. Clinical and biochemical investigations indicated acceptable biocompatibility of the device.
CONCLUSION: The implantation technique for the ASDOS device in a chronic pig model has been established. Biocompatibility of the device was acceptable.

Entities:  

Mesh:

Year:  1998        PMID: 10065032      PMCID: PMC1728873          DOI: 10.1136/hrt.80.6.606

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Transvenous atrial septal defect occlusion by the buttoned device.

Authors:  E B Sideris; S E Sideris; B D Thanopoulos; R L Ehly; J P Fowlkes
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

2.  Transcatheter closure of atrial septal defects. Past, present, and future.

Authors:  A P Rocchini
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

3.  Secundum atrial septal defect. Nonoperative closure during cardiac catheterization.

Authors:  T D King; S L Thompson; C Steiner; N L Mills
Journal:  JAMA       Date:  1976-06-07       Impact factor: 56.272

4.  Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia.

Authors:  J Roussi; P André; M Samama; G Pignaud; M Bonneau; A Laporte; L Drouet
Journal:  Thromb Res       Date:  1996-02-01       Impact factor: 3.944

5.  Transcatheter closure of atrial septal defects. Experimental studies.

Authors:  J E Lock; J J Rome; R Davis; S Van Praagh; S B Perry; R Van Praagh; J F Keane
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

6.  Double-umbrella closure of atrial defects. Initial clinical applications.

Authors:  J J Rome; J F Keane; S B Perry; P J Spevak; J E Lock
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

7.  Biological response to Bard Clamshell Septal Occluders in the canine heart.

Authors:  M A Kuhn; L A Latson; J P Cheatham; B McManus; J M Anderson; K L Kilzer; J Furst
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

8.  Experimental atrial septal defect closure with a new, transcatheter, self-centering device.

Authors:  G S Das; G Voss; G Jarvis; K Wyche; R Gunther; R F Wilson
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

9.  Management of complications of Sideris transcatheter devices for atrial septal defect closure.

Authors:  F A Arabia; L J Rosado; T R Lloyd; G K Sethi
Journal:  J Thorac Cardiovasc Surg       Date:  1993-11       Impact factor: 5.209

10.  International experience with secundum atrial septal defect occlusion by the buttoned device.

Authors:  P S Rao; E B Sideris; G Hausdorf; C Rey; T R Lloyd; R H Beekman; A M Worms; F Bourlon; E Onorato; M Khalilullah
Journal:  Am Heart J       Date:  1994-11       Impact factor: 4.749

View more
  3 in total

1.  Biocompatibility of septal defect closure devices.

Authors:  Matthias Sigler; Christian Jux
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

Review 2.  Role of animal models for percutaneous atrial septal defect closure.

Authors:  Zakaria Jalal; Pierre-Emmanuel Seguela; Alban-Elouen Baruteau; David Benoist; Olivier Bernus; Olivier Villemain; Younes Boudjemline; Xavier Iriart; Jean-Benoit Thambo
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.

Authors:  Bo-Ning Li; Quan-Dong Tang; Yan-Lian Tan; Liang Yan; Ling Sun; Wei-Bing Guo; Ming-Yang Qian; Allen Chen; Ying-Jun Luo; Zhou-Xia Zheng; Zhi-Wei Zhang; Hong-Ling Jia; Cong Liu
Journal:  Front Genet       Date:  2021-12-08       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.